Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-043432

Chief Commercial Officer sold 19,900 shares at an average $90.35 ($1,798,002)

  • Chief Commercial Officer acquired 19,900 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-08 Exercise or conversion : show line 1 in the form 10b5-1 +4,388 $16.14 $70,822 29,573 D
2024-04-08 Sale : show line 2 in the form 10b5-1 −4,388 $90.00 $394,920 25,185 D
2024-04-09 Exercise or conversion : show line 3 in the form 10b5-1 +8,341 $16.14 $134,624 33,526 D
2024-04-09 Exercise or conversion : show line 4 in the form 10b5-1 +7,171 $38.46 $275,797 40,697 D
2024-04-09 Sale : show line 5 in the form 10b5-1 −10,532 $90.14 $949,354 30,165 D
2024-04-09 Sale : show line 6 in the form 10b5-1 −4,980 $91.11 $453,728 25,185 D
Open-market sales · 19,900 sh · avg $90.35 · $1,798,002

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-04-08 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −4,388 8,341 D
2024-04-09 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −8,341 0 D
2024-04-09 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) −7,171 61,368 D
Loading xslF345X05/ownership.xml…